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Background
Although oversedation has been associated with increased morbidity in ventilated
critically ill patients, it is unclear whether prevention of oversedation improves
mortality. We aimed to assess 90-day mortality in patients receiving a bundle of
interventions to prevent oversedation as compared to usual care.
Methods
In this randomized multicentre trial, all adult patients requiring mechanical
ventilation for more than 48 h were included. Two groups were compared: patients
managed according to usual sedation practices (control), and patients receiving
sedation according to an algorithm which provided a gradual multilevel response to
pain, agitation, and ventilator dyssynchrony with no specific target to alter
consciousness and no use of sedation scale and promoted the use of alternatives to
continuous infusion of midazolam or propofol (intervention).
Results
Inclusions were stopped before reaching the planned enrolment. Between 2012 and
2014, 584 patients were included in the intervention group and 590 in the control
group. Baseline characteristics were well balanced between groups. Although the use
of midazolam and propofol was significantly lower in the intervention group, 90-day
mortality was not significantly lower (39.4 vs. 44.2% in the control group, p = 0.09).
There were no significant differences in 1-year mortality between the two groups. The
time to first spontaneous breathing trial and time to successful extubation were
significantly shorter in the intervention group than in the control group. These last
results should be interpreted with precaution regarding the several limitations of the
trial including the early termination.
Conclusions
This underpowered study of severely ill patients was unable to show that a strategy to
prevent oversedation could significantly reduce mortality.
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